134 related articles for article (PubMed ID: 11289075)
1. QSAR study and VolSurf characterization of anti-HIV quinolone library.
Filipponi E; Cruciani G; Tabarrini O; Cecchetti V; Fravolini A
J Comput Aided Mol Des; 2001 Mar; 15(3):203-17. PubMed ID: 11289075
[TBL] [Abstract][Full Text] [Related]
2. Studies of anti-HIV transcription inhibitor quinolones: identification of potent N1-vinyl derivatives.
Tabarrini O; Massari S; Daelemans D; Meschini F; Manfroni G; Bottega L; Gatto B; Palumbo M; Pannecouque C; Cecchetti V
ChemMedChem; 2010 Nov; 5(11):1880-92. PubMed ID: 20928882
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
[TBL] [Abstract][Full Text] [Related]
4. Quinolone derivatives: Potential anti-HIV agent-development and application.
Wang R; Xu K; Shi W
Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900045. PubMed ID: 31274223
[TBL] [Abstract][Full Text] [Related]
5. Modeling anti-HIV compounds: the role of analogue-based approaches.
Srivastava HK; Bohari MH; Sastry GN
Curr Comput Aided Drug Des; 2012 Sep; 8(3):224-48. PubMed ID: 22734706
[TBL] [Abstract][Full Text] [Related]
6. Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands.
Sancineto L; Iraci N; Barreca ML; Massari S; Manfroni G; Corazza G; Cecchetti V; Marcello A; Daelemans D; Pannecouque C; Tabarrini O
Bioorg Med Chem; 2014 Sep; 22(17):4658-66. PubMed ID: 25127466
[TBL] [Abstract][Full Text] [Related]
7. QSAR and Pharmacophore Mapping Studies on Benzothiazinimines to Relate their Structural Features with anti-HIV Activity.
Geethaavacini G; Poh GP; Yan LY; Deepashini R; Shalini S; Harish R; Sureshkumar K; Ravichandran V
Med Chem; 2018; 14(7):733-740. PubMed ID: 29807521
[TBL] [Abstract][Full Text] [Related]
8. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
[TBL] [Abstract][Full Text] [Related]
9. Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity.
He QQ; Gu SX; Liu J; Wu HQ; Zhang X; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Aug; 19(16):5039-45. PubMed ID: 21763149
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Structure-activity Relationship Study of Betulinic Acid Derivatives Against HIV using SMILES-based Descriptors.
Worachartcheewan A; Toropova AP; Toropov AA; Siriwong S; Prapojanasomboon J; Prachayasittikul V; Nantasenamat C
Curr Comput Aided Drug Des; 2018; 14(2):152-159. PubMed ID: 29332601
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship study on anti-HIV 6-desfluoroquinolones.
Tabarrini O; Massari S; Daelemans D; Stevens M; Manfroni G; Sabatini S; Balzarini J; Cecchetti V; Pannecouque C; Fravolini A
J Med Chem; 2008 Sep; 51(17):5454-8. PubMed ID: 18710207
[TBL] [Abstract][Full Text] [Related]
12. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
[TBL] [Abstract][Full Text] [Related]
13. Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance Profile.
Mao TQ; He QQ; Chen WX; Tang GF; Chen FE; De Clercq E; Daelemans D; Pannecouque C
Curr Pharm Des; 2016; 22(46):6982-6987. PubMed ID: 27875973
[TBL] [Abstract][Full Text] [Related]
14. Studies on anti-HIV quinolones: new insights on the C-6 position.
Massari S; Daelemans D; Manfroni G; Sabatini S; Tabarrini O; Pannecouque C; Cecchetti V
Bioorg Med Chem; 2009 Jan; 17(2):667-74. PubMed ID: 19091580
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.
Chen KX; Xie HY; Li ZG; Gao JR
Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162
[TBL] [Abstract][Full Text] [Related]
16. Anilides and quinolones with nitrogen-bearing substituents from benzothiophene and thienothiophene series: synthesis, photochemical synthesis, cytostatic evaluation, 3D-derived QSAR analysis and DNA-binding properties.
Aleksić M; Bertoša B; Nhili R; Depauw S; Martin-Kleiner I; David-Cordonnier MH; Tomić S; Kralj M; Karminski-Zamola G
Eur J Med Chem; 2014 Jan; 71():267-81. PubMed ID: 24334150
[TBL] [Abstract][Full Text] [Related]
17. "In silico" design of potential anti-HIV actives using fragment descriptors.
Varnek A; Solov'ev VP
Comb Chem High Throughput Screen; 2005 Aug; 8(5):403-16. PubMed ID: 16101580
[TBL] [Abstract][Full Text] [Related]
18. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
[TBL] [Abstract][Full Text] [Related]
19. In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives.
Estrada E; Vilar S; Uriarte E; Gutierrez Y
J Chem Inf Comput Sci; 2002; 42(5):1194-203. PubMed ID: 12377009
[TBL] [Abstract][Full Text] [Related]
20. QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method.
Toropova AP; Toropov AA; Veselinović JB; Miljković FN; Veselinović AM
Eur J Med Chem; 2014 Apr; 77():298-305. PubMed ID: 24657566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
